Towards defining follow-up strategies for patients with primary (first diagnosis) EAU2021 intermediate-risk non-muscle invasive bladder cancer.

R Contieri; I Beijert; A Martini; EM Camperat; Hernandez; HM Bruins; JL Dominguez-Escrig; F Liedberg; A Masson-Lecomte; D Cohen; H Mostafid; SF Shariat; M Roupret; B Pradere; Richard Zigeuner; F Soria; Soukup; JP Redorta; O Capoun; M Burger; P Gontero; R Sylvester; L Mertens; BWG Van Rhijn

Towards defining follow-up strategies for patients with primary (first diagnosis) EAU2021 intermediate-risk non-muscle invasive bladder cancer.

R Contieri
, I Beijert
, A Martini
, EM Camperat
, Hernandez
, HM Bruins
, JL Dominguez-Escrig
, F Liedberg
, A Masson-Lecomte
, D Cohen
, H Mostafid
, SF Shariat
, M Roupret
, B Pradere
, Richard Zigeuner
, F Soria
, Soukup
, JP Redorta
, O Capoun
, M Burger

P Gontero, R Sylvester, L Mertens, BWG Van Rhijn

Department of Urology

Research output: Contribution to journal › Conference abstract

Original language	English
Pages (from-to)	S1164-S1165
Number of pages	2
Journal	European Urology
Volume	85
Publication status	Published - Mar 2024
Event	39th Annual Meeting of the European Association of Urology - Paris, France Duration: 5 Apr 2024 → 8 Apr 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Branches of science

302 Clinical Medicine

Cite this

Contieri, R., Beijert, I., Martini, A., Camperat, EM., Hernandez, Bruins, HM., Dominguez-Escrig, JL., Liedberg, F., Masson-Lecomte, A., Cohen, D., Mostafid, H., Shariat, SF., Roupret, M., Pradere, B., Zigeuner, R., Soria, F., Soukup, Redorta, JP., Capoun, O., ... Van Rhijn, BWG. (2024). Towards defining follow-up strategies for patients with primary (first diagnosis) EAU2021 intermediate-risk non-muscle invasive bladder cancer. European Urology, 85, S1164-S1165.

@article{d77f285202054ebcb71973ed6e46458a,

title = "Towards defining follow-up strategies for patients with primary (first diagnosis) EAU2021 intermediate-risk non-muscle invasive bladder cancer.",

author = "R Contieri and I Beijert and A Martini and EM Camperat and Hernandez and HM Bruins and JL Dominguez-Escrig and F Liedberg and A Masson-Lecomte and D Cohen and H Mostafid and SF Shariat and M Roupret and B Pradere and Richard Zigeuner and F Soria and Soukup and JP Redorta and O Capoun and M Burger and P Gontero and R Sylvester and L Mertens and \{Van Rhijn\}, BWG",

year = "2024",

month = mar,

language = "English",

volume = "85",

pages = "S1164--S1165",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier B.V.",

note = "39th Annual Meeting of the European Association of Urology, EAU 39 ; Conference date: 05-04-2024 Through 08-04-2024",

}

Contieri, R, Beijert, I, Martini, A, Camperat, EM, Hernandez, Bruins, HM, Dominguez-Escrig, JL, Liedberg, F, Masson-Lecomte, A, Cohen, D, Mostafid, H, Shariat, SF, Roupret, M, Pradere, B, Zigeuner, R, Soria, F, Soukup, Redorta, JP, Capoun, O, Burger, M, Gontero, P, Sylvester, R, Mertens, L & Van Rhijn, BWG 2024, 'Towards defining follow-up strategies for patients with primary (first diagnosis) EAU2021 intermediate-risk non-muscle invasive bladder cancer.', European Urology, vol. 85, pp. S1164-S1165.

TY - JOUR

T1 - Towards defining follow-up strategies for patients with primary (first diagnosis) EAU2021 intermediate-risk non-muscle invasive bladder cancer.

AU - Contieri, R

AU - Beijert, I

AU - Martini, A

AU - Camperat, EM

AU - Hernandez, null

AU - Bruins, HM

AU - Dominguez-Escrig, JL

AU - Liedberg, F

AU - Masson-Lecomte, A

AU - Cohen, D

AU - Mostafid, H

AU - Shariat, SF

AU - Roupret, M

AU - Pradere, B

AU - Zigeuner, Richard

AU - Soria, F

AU - Soukup, null

AU - Redorta, JP

AU - Capoun, O

AU - Burger, M

AU - Gontero, P

AU - Sylvester, R

AU - Mertens, L

AU - Van Rhijn, BWG

PY - 2024/3

Y1 - 2024/3

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:001282821401119

M3 - Conference abstract

SN - 0302-2838

VL - 85

SP - S1164-S1165

JO - European Urology

JF - European Urology

T2 - 39th Annual Meeting of the European Association of Urology

Y2 - 5 April 2024 through 8 April 2024

ER -

Towards defining follow-up strategies for patients with primary (first diagnosis) EAU2021 intermediate-risk non-muscle invasive bladder cancer.

UN SDGs

Branches of science

Links

Cite this